Novavax Inc vs Wolfspeed Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Wolfspeed Inc trades at $32.42 (market cap $1.53B). The key difference: Wolfspeed Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| NVAX | WOLF | |
|---|---|---|
Market Cap | $1.30B | $1.53B |
Sector | Health | Technology |
52-Week High | $11.19 | $73.68 |
52-Week Low | $6.22 | $1.19 |
Enterprise Value | $800.50M | $2.19B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WOLF trades at $29.38, down 1.71% with bearish technical signals despite oversold RSI readings. The company shows negative profitability metrics with -79.83% net income margin and -14.54% ROE, though recent earnings beat expectations in two of three quarters. Strategic shifts toward data centers and defense markets alongside patent litigation activity create mixed sentiment.
Outlook remains challenging due to persistent losses and competitive pressures, though analyst consensus leans slightly bullish with 31.58% buy ratings. Key risks include execution on margin improvement and market share battles in the competitive semiconductor space.
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →